|
| | 98TH GENERAL ASSEMBLY
State of Illinois
2013 and 2014 HB2661 Introduced 2/21/2013, by Rep. Robyn Gabel SYNOPSIS AS INTRODUCED: |
| 210 ILCS 3/85 new | | 210 ILCS 85/17 new | |
|
Amends the Alternative Health Care Delivery Act and the Hospital Licensing Act. Sets forth the General Assembly's findings concerning the screening of newborns for congenital heart defects. Provides that all birth centers and hospitals must test every newborn for congenital heart defects via a screening test in line with the current standard of care, such as pulse oximetry screening, according to congenital heart defect screening protocols developed by the Department of Public Health in consultation with relevant medical practitioners and stakeholders. Provides that exceptions to mandatory congenital heart defect screenings shall be limited to cases in which the parents object to the screening, or as directed by the congenital heart defect screening protocol.
|
| |
| | A BILL FOR |
|
|
| | HB2661 | | LRB098 09098 RPM 39235 b |
|
|
1 | | AN ACT concerning health facilities.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Alternative Health Care Delivery Act is |
5 | | amended by adding Section 85 as follows: |
6 | | (210 ILCS 3/85 new) |
7 | | Sec. 85. Newborn screening; congenital heart defects. |
8 | | (a) The General Assembly finds as follows: |
9 | | (1) Congenital heart defects (CHDs) are structural |
10 | | abnormalities of the heart that are
present at birth. CHDs |
11 | | range in severity from simple problems such as holes |
12 | | between
chambers of the heart to severe malformations, such |
13 | | as the complete absence of one or more
chambers or valves. |
14 | | Some critical CHDs can cause severe and life-threatening |
15 | | symptoms
that require intervention within the first days of |
16 | | life. |
17 | | (2) According to the United States Secretary of Health |
18 | | and Human Services' Advisory
Committee on Heritable |
19 | | Disorders in Newborns and Children, congenital heart |
20 | | disease
affects approximately 7 to 9 of every 1,000 live |
21 | | births in the United States and
Europe. The federal Centers |
22 | | for Disease Control and Prevention states that CHD is the
|
23 | | leading cause of infant death due to birth defects. |
|
| | HB2661 | - 2 - | LRB098 09098 RPM 39235 b |
|
|
1 | | (3) Current methods for detecting CHDs generally |
2 | | include prenatal ultrasound screening
and repeated |
3 | | clinical examinations. While prenatal ultrasound |
4 | | screenings can detect some
major congenital heart defects, |
5 | | these screenings, alone, identify less than half of all CHD
|
6 | | cases, and critical CHD cases are often missed during |
7 | | routine clinical exams performed prior
to a newborn's |
8 | | discharge from a birthing facility. |
9 | | (4) Pulse oximetry is a non-invasive test that |
10 | | estimates the percentage of hemoglobin in
blood that is |
11 | | saturated with oxygen. When performed on a newborn within a |
12 | | minimum of 24 hours
after birth, pulse oximetry screening |
13 | | is often more effective at detecting critical, |
14 | | life-threatening
CHDs that otherwise go undetected by |
15 | | current screening methods. Newborns
with abnormal pulse |
16 | | oximetry results require immediate confirmatory testing |
17 | | and
intervention. |
18 | | (5) Many newborn lives could potentially be saved by |
19 | | earlier detection and treatment of
CHDs if birthing |
20 | | facilities in the State were required to perform this |
21 | | simple, non-invasive
newborn screening in conjunction with |
22 | | current CHD screening methods. |
23 | | (b) All birth centers must test every newborn for |
24 | | congenital heart defects via a screening test in line with the |
25 | | current standard of care, such as pulse oximetry screening, |
26 | | according to congenital heart defect screening protocols |
|
| | HB2661 | - 3 - | LRB098 09098 RPM 39235 b |
|
|
1 | | developed by the Department of Public Health in consultation |
2 | | with relevant medical practitioners and stakeholders. |
3 | | (c) Exceptions to mandatory congenital heart defect |
4 | | screenings shall be limited to cases in which the parents |
5 | | object to the screening, or as directed by the congenital heart |
6 | | defect screening protocol. |
7 | | Section 10. The Hospital Licensing Act is amended by adding |
8 | | Section 17 as follows: |
9 | | (210 ILCS 85/17 new) |
10 | | Sec. 17. Newborn screening; congenital heart defects. |
11 | | (a) The General Assembly finds as follows: |
12 | | (1) Congenital heart defects (CHDs) are structural |
13 | | abnormalities of the heart that are
present at birth. CHDs |
14 | | range in severity from simple problems such as holes |
15 | | between
chambers of the heart to severe malformations, such |
16 | | as the complete absence of one or more
chambers or valves. |
17 | | Some critical CHDs can cause severe and life-threatening |
18 | | symptoms
that require intervention within the first days of |
19 | | life. |
20 | | (2) According to the United States Secretary of Health |
21 | | and Human Services' Advisory
Committee on Heritable |
22 | | Disorders in Newborns and Children, congenital heart |
23 | | disease
affects approximately 7 to 9 of every 1,000 live |
24 | | births in the United States and
Europe. The federal Centers |
|
| | HB2661 | - 4 - | LRB098 09098 RPM 39235 b |
|
|
1 | | for Disease Control and Prevention states that CHD is the
|
2 | | leading cause of infant death due to birth defects. |
3 | | (3) Current methods for detecting CHDs generally |
4 | | include prenatal ultrasound screening
and repeated |
5 | | clinical examinations. While prenatal ultrasound |
6 | | screenings can detect some
major congenital heart defects, |
7 | | these screenings, alone, identify less than half of all CHD
|
8 | | cases, and critical CHD cases are often missed during |
9 | | routine clinical exams performed prior
to a newborn's |
10 | | discharge from a birthing facility. |
11 | | (4) Pulse oximetry is a non-invasive test that |
12 | | estimates the percentage of hemoglobin in
blood that is |
13 | | saturated with oxygen. When performed on a newborn within a |
14 | | minimum of 24 hours
after birth, pulse oximetry screening |
15 | | is often more effective at detecting critical, |
16 | | life-threatening
CHDs that otherwise go undetected by |
17 | | current screening methods. Newborns
with abnormal pulse |
18 | | oximetry results require immediate confirmatory testing |
19 | | and
intervention. |
20 | | (5) Many newborn lives could potentially be saved by |
21 | | earlier detection and treatment of
CHDs if birthing |
22 | | facilities in the State were required to perform this |
23 | | simple, non-invasive
newborn screening in conjunction with |
24 | | current CHD screening methods. |
25 | | (b) All hospitals must test every newborn for congenital |
26 | | heart defects via a screening test in line with the current |
|
| | HB2661 | - 5 - | LRB098 09098 RPM 39235 b |
|
|
1 | | standard of care, such as pulse oximetry screening, according |
2 | | to congenital heart defect screening protocols developed by the |
3 | | Department of Public Health in consultation with relevant |
4 | | medical practitioners and stakeholders. |
5 | | (c) Exceptions to mandatory congenital heart defect |
6 | | screenings shall be limited to cases in which the parents |
7 | | object to the screening, or as directed by the congenital heart |
8 | | defect screening protocol.
|